Linagliptin Mākua Nucleus Intermediate CAS 853029-57-9 Maʻemaʻe ≥99.0% Factory
Hāʻawi ka mea hana i ka Linagliptin a me nā mea pili e pili ana:
Linagliptin CAS 668270-12-0
Linagliptin Mākua Nucleus Intermediate CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0
Inoa Kimia | 8-Bromo-7-akā-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl) -3,7-dihydro-purine-2,6-dione |
Nā huaʻōlelo like | Linagliptin Mākua Nucleus;ʻO Linagliptin Intermediate F |
Helu CAS | 853029-57-9 |
Helu CAT | RF-PI502 |
Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona |
ʻĀpana Molekala | C20H17BrN6O2 |
Kaumaha Molecular | 453.29 |
Brand | ʻO Ruifu Chemical |
'ikamu | Nā kikoʻī |
Ka nana aku | Keokeo a i ka pauda Melemele Malamalama |
ʻIkepili | IR/HPLC |
Maemae | ≥99.0% |
Wai (KF) | ≤1.0% |
Koena ma ka Ignition | ≤0.50% |
Huina paumaele | ≤1.0% |
Kūlana hoʻāʻo | ʻOihana Kūlana |
Hoʻohana | Waena no Linagliptin (CAS: 668270-12-0) |
Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.
8-Bromo-7-akā-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl) -3,7-dihydro-purine-2,6-dione (CAS: 853029-57- 9) ʻo ia ka nucleus makua o Linagliptin (CAS: 668270-12-0).ʻO Linagliptin (nā inoa kālepa ʻo Tradjenta a me Trajetna) he mea hoʻopale o dipeptidyl peptidase-4 (DPP-4) i ʻae ʻia e ka US FDA i Mei 2011 no ka mālama ʻana i ka maʻi maʻi type 2 me ka ʻai a me ka hoʻoikaika kino.Ua wehewehe ʻia ʻo Linagliptin (BI-1356) ma ke ʻano he mea koho nui loa, lohi-off rate a me ka hana lōʻihi o DPP-4.Ua kū mai ʻo Linagliptin mai ka hoʻoikaika ʻana o ka xanthine-based DPP-4 inhibitors me ke alakaʻi mua i ʻike ʻia mai kahi hoʻolaha HTS.